Home Sulfos N-[[5-(Dimethylamino)-1-naphthalenyl]sulfonyl]-N-methylglycine

N-[[5-(Dimethylamino)-1-naphthalenyl]sulfonyl]-N-methylglycine

CAS No.:
1093-96-5
Catalog Number:
AG003ARJ
Molecular Formula:
C15H18N2O4S
Molecular Weight:
322.3794
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG003ARJ
Chemical Name:
N-[[5-(Dimethylamino)-1-naphthalenyl]sulfonyl]-N-methylglycine
CAS Number:
1093-96-5
Molecular Formula:
C15H18N2O4S
Molecular Weight:
322.3794
MDL Number:
MFCD00069542
IUPAC Name:
2-[[5-(dimethylamino)naphthalen-1-yl]sulfonyl-methylamino]acetic acid
InChI:
InChI=1S/C15H18N2O4S/c1-16(2)13-8-4-7-12-11(13)6-5-9-14(12)22(20,21)17(3)10-15(18)19/h4-9H,10H2,1-3H3,(H,18,19)
InChI Key:
BRLJKBOXIVONAG-UHFFFAOYSA-N
SMILES:
OC(=O)CN(S(=O)(=O)c1cccc2c1cccc2N(C)C)C
Properties
Complexity:
500  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
322.099g/mol
Formal Charge:
0
Heavy Atom Count:
22  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
322.379g/mol
Monoisotopic Mass:
322.099g/mol
Rotatable Bond Count:
5  
Topological Polar Surface Area:
86.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.2  
Literature
Title Journal
Effect of oxidative stress and endotoxin on human serum albumin in brain-dead organ donors. Translational research : the journal of laboratory and clinical medicine 20120601
Pollutant-induced modulation in conformation and β-lactamase activity of human serum albumin. PloS one 20120101
Effects of nonenzymatic glycation and fatty acids on functional properties of human albumin. Metabolism: clinical and experimental 20111201
Binding of citrus flavanones and their glucuronides and chalcones to human serum albumin. Food & function 20111001
Enantioselective binding of a lanthanide(III) complex to human serum albumin studied by 1H STD NMR techniques. Organic & biomolecular chemistry 20110721
Structural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albumin. Journal of structural biology 20110401
A combined spectroscopic and crystallographic approach to probing drug-human serum albumin interactions. Bioorganic & medicinal chemistry 20101101
Modeling kinetics of subcellular disposition of chemicals. Chemical reviews 20090513
Olive phenols efficiently inhibit the oxidation of serum albumin-bound linoleic acid and butyrylcholine esterase. Biochimica et biophysica acta 20090401
A fluorescence study of human serum albumin binding sites modification by hypochlorite. Journal of photochemistry and photobiology. B, Biology 20090209
Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 20080901
Structural and ligand-binding properties of serum albumin species interacting with a biomembrane interface. Journal of pharmaceutical sciences 20071101
Human serum albumin binding assay based on displacement of a non selective fluorescent inhibitor. Bioorganic & medicinal chemistry letters 20070815
Albumin-binding PARACEST agents. Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20070801
Determination of drug-serum protein interactions via fluorescence polarization measurements. Analytical and bioanalytical chemistry 20070701
Albumin-binding function is reduced in patients with decompensated cirrhosis and correlates inversely with severity of liver disease assessed by model for end-stage liver disease. European journal of gastroenterology & hepatology 20070301
Synthesis and physicochemical characterization of two gadolinium(III) TTDA-like complexes and their interaction with human serum albumin. Inorganic chemistry 20060109
Interaction of non-steroidal anti-inflammatory drugs, etoricoxib and parecoxib sodium, with human serum albumin studied by fluorescence spectroscopy. Drug metabolism and drug interactions 20060101
High-throughput solution-based medicinal library screening against human serum albumin. Analytical chemistry 20050301
Inhibitory effects of amino-acid fluids on drug binding to site II of human serum albumin in vitro. Biological & pharmaceutical bulletin 20050301
The interaction of human serum albumin with a novel antidiabetic agent--SU-118. Journal of pharmaceutical sciences 20040401
The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants. Biochimica et biophysica acta 20031013
The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. Journal of the American Chemical Society 20020327
The Gd(3+) complex of a fatty acid analogue of DOTP binds to multiple albumin sites with variable water relaxivities. Inorganic chemistry 20011217
In vitro and in vivo properties of recombinant human serum albumin from Pichia pastoris purified by a method of short processing time. Pharmaceutical research 20011201
Flunitrazepam, a 7-nitro-1,4-benzodiazepine that is unable to bind to the indole-benzodiazepine site of human serum albumin. Biochimica et biophysica acta 20010407
Reversible binding of the novel anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid to plasma proteins and its distribution into blood cells in various species. The Journal of pharmacy and pharmacology 20010401
Interaction mechanism between indoxyl sulfate, a typical uremic toxin bound to site II, and ligands bound to site I of human serum albumin. Pharmaceutical research 20010401
Properties